Chemical Component Summary

NameN-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea
Identifiers1-[(2~{S})-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2~{S})-1-thiophen-3-ylpropan-2-yl]urea
FormulaC19 H27 N3 O2 S
Molecular Weight361.502
TypeNON-POLYMER
Isomeric SMILESC[C@@H](Cc1ccsc1)NC(=O)NC[C@H](Cc2ccc(cc2)O)N(C)C
InChIInChI=1S/C19H27N3O2S/c1-14(10-16-8-9-25-13-16)21-19(24)20-12-17(22(2)3)11-15-4-6-18(23)7-5-15/h4-9,13-14,17,23H,10-12H2,1-3H3,(H2,20,21,24)/t14-,17-/m0/s1
InChIKeyMEDBIJOVZJEMBI-YOEHRIQHSA-N

Chemical Details

Formal Charge0
Atom Count52
Chiral Atom Count2
Bond Count53
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB14030 
NamePZM21
Groups experimental
DescriptionPZM21 is a novel μ-opioid receptor (MOPr) ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ-opioid ligands such as morphine. [A33051]
SynonymsPZM21
CAS number1997387-43-5

Related Resource References

Resource NameReference
Pharos CHEMBL4467777
PubChem 121596705
ChEMBL CHEMBL4467777